ES431675A1 - Un procedimiento para preparar compuestos de hexahidro-di- benzo(b,d) piran-9-ona. - Google Patents

Un procedimiento para preparar compuestos de hexahidro-di- benzo(b,d) piran-9-ona.

Info

Publication number
ES431675A1
ES431675A1 ES431675A ES431675A ES431675A1 ES 431675 A1 ES431675 A1 ES 431675A1 ES 431675 A ES431675 A ES 431675A ES 431675 A ES431675 A ES 431675A ES 431675 A1 ES431675 A1 ES 431675A1
Authority
ES
Spain
Prior art keywords
dibenzo
hexahydro
pyran
ones
anxiety drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES431675A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES431675A1 publication Critical patent/ES431675A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
ES431675A 1973-11-05 1974-11-05 Un procedimiento para preparar compuestos de hexahidro-di- benzo(b,d) piran-9-ona. Expired ES431675A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US413009A US3928598A (en) 1973-11-05 1973-11-05 Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug

Publications (1)

Publication Number Publication Date
ES431675A1 true ES431675A1 (es) 1977-04-16

Family

ID=23635412

Family Applications (1)

Application Number Title Priority Date Filing Date
ES431675A Expired ES431675A1 (es) 1973-11-05 1974-11-05 Un procedimiento para preparar compuestos de hexahidro-di- benzo(b,d) piran-9-ona.

Country Status (25)

Country Link
US (1) US3928598A (es)
JP (1) JPS6033834B2 (es)
AR (1) AR206409A1 (es)
AT (1) AT337178B (es)
BE (1) BE821719A (es)
BG (1) BG25995A3 (es)
CA (1) CA1029383A (es)
CH (1) CH611290A5 (es)
CS (1) CS193506B2 (es)
DD (1) DD116229A5 (es)
DE (1) DE2451932C2 (es)
DK (1) DK136718B (es)
ES (1) ES431675A1 (es)
FR (1) FR2249663B1 (es)
GB (1) GB1487636A (es)
HU (1) HU169192B (es)
IE (1) IE40025B1 (es)
IL (1) IL45662A (es)
NL (1) NL180979C (es)
PH (1) PH10476A (es)
PL (2) PL100502B1 (es)
SE (1) SE415761B (es)
SU (1) SU515457A3 (es)
YU (1) YU36946B (es)
ZA (1) ZA745794B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4102902A (en) * 1976-11-10 1978-07-25 Eli Lilly And Company Stereoselective preparation of hexahydro dibenzopyranones and intermediates therefor
US4351833A (en) * 1980-07-28 1982-09-28 Pfizer Inc. 9-Amino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof as analgesics and anti-emetics
US4309545A (en) * 1980-07-28 1982-01-05 Pfizer Inc. Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof
US5498419A (en) * 1994-06-03 1996-03-12 Pars; Harry G. Fumarate salt of 4-(diethyl-3-(1-methyloctyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol, 4-(diethyl-amino) butyric
ATE247097T1 (de) * 1998-05-04 2003-08-15 Univ Connecticut Analgetische und immunomodulierende cannabinoiden
US7589220B2 (en) * 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7897598B2 (en) * 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US7119108B1 (en) 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
US6900236B1 (en) * 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
AU778159B2 (en) 1999-10-18 2004-11-18 University Of Connecticut, The Peripheral cannabinoid receptor (CB2) selective ligands
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US6943266B1 (en) * 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
WO2002026728A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
WO2002026224A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
US7329651B2 (en) * 2001-01-26 2008-02-12 University Of Connecticut Cannabimimetic ligands
JP2005503998A (ja) 2001-01-29 2005-02-10 ユニバーシティ オブ コネチカット 受容体選択性のカンナビミメティックアミノアルキルインドール
JP4312594B2 (ja) * 2001-07-13 2009-08-12 ユニバーシティ オブ コネチカット 新規な二環式及び三環式カンナビノイド
US7666867B2 (en) * 2001-10-26 2010-02-23 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
WO2003080043A1 (en) * 2002-03-18 2003-10-02 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
CN1678303A (zh) 2002-08-23 2005-10-05 康涅狄格大学 具有治疗作用的酮类大麻类

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans

Also Published As

Publication number Publication date
IL45662A0 (en) 1974-11-29
AT337178B (de) 1977-06-10
SE7413832L (es) 1975-05-06
DK136718C (es) 1978-04-24
PH10476A (en) 1977-05-11
SE415761B (sv) 1980-10-27
AU7329074A (en) 1976-03-18
YU261974A (en) 1982-06-18
SU515457A3 (ru) 1976-05-25
BG25995A3 (es) 1979-01-12
CA1029383A (en) 1978-04-11
ATA886274A (de) 1976-10-15
YU36946B (en) 1984-08-31
FR2249663B1 (es) 1978-03-24
CS193506B2 (en) 1979-10-31
IE40025L (en) 1975-05-05
NL7414437A (nl) 1975-05-07
NL180979B (nl) 1987-01-02
DE2451932A1 (de) 1975-05-07
ZA745794B (en) 1976-04-28
BE821719A (fr) 1975-04-30
PL94965B1 (es) 1977-09-30
GB1487636A (en) 1977-10-05
PL100502B1 (pl) 1978-10-31
NL180979C (nl) 1987-06-01
DK136718B (da) 1977-11-14
DK573174A (es) 1975-07-07
DD116229A5 (es) 1975-11-12
FR2249663A1 (es) 1975-05-30
IE40025B1 (en) 1979-02-28
HU169192B (es) 1976-10-28
JPS6033834B2 (ja) 1985-08-05
IL45662A (en) 1978-03-10
US3928598A (en) 1975-12-23
JPS5082073A (es) 1975-07-03
DE2451932C2 (de) 1983-09-29
AR206409A1 (es) 1976-07-23
CH611290A5 (es) 1979-05-31

Similar Documents

Publication Publication Date Title
ES431675A1 (es) Un procedimiento para preparar compuestos de hexahidro-di- benzo(b,d) piran-9-ona.
ES431674A1 (es) Un procedimiento para preparar hexahidrodibenzo (b, d) pi- ranos.
ES413944A1 (es) Procedimiento para la preparacion de compuestos de adamen- tano trisustituidos en las posiciones 1,3,5.
JO1502B1 (en) New pharmacy vehicles
IL46259A0 (en) New phenoxypropylamine derivatives,their preparation and pharmaceutical compositions containing them
EG18379A (en) Novel pharmacological compounds
IL41784A0 (en) Novel optically active derivatives of 1-phenyl-2-aminoethanol,their preparation and pharmaceutical compositions containing them
GB1341794A (en) Medicament for the treatment of hepatic disorders
IL44418A0 (en) Novel benzodiazepines,their preparation and pharmaceutical compositions containing them
PH10450A (en) Alkylphenyl benzopyranopyridines,pharmaceutical compositions and method of use thereof
EP0003200A3 (en) Use of tetrahydropyridinyl indole derivatives as medicines, and pharmaceutical compositions containing them
GB1446237A (en) Pharmaceutical preparations containing pyrazolones
GB1346405A (en) Pharmaceutical composition useful as an anti-depressant agent and an anti-parkinsonism agent
GB1160846A (en) Anti-Inflammatory Substance, Zygosporin A, and the production thereof
GB1340528A (en) Psychotropic medicinal composition
IL44777A0 (en) New 6-aza-1,4-benzodiazepines,their preparation and pharmaceutical compositions containing them
IL42030A (en) 1,4-disubstituted piperazines,their preparation and pharmaceutical compositions containing them
ATE14837T1 (de) Pharmazeutische zusammensetzungen.
GB1415055A (en) Pharmaceutical compositions
JO1531B1 (en) New near-compounds
IL44778A0 (en) New 6-aza-1,2-dihidro-3h-1,4-benzodiazepines,their preparation and pharmaceutical compositions containing them
GB1305738A (es)
PH9489A (en) N'-(1,2-dihydro-2-oxo-4-pyrimidenyl)sulfanilamides and pharmaceutical compositions containing them
GB1454872A (en) Anticonvulsant
CA815003A (en) 9.beta., 10.alpha.-STEROIDS, METHODS OF PRODUCING THESE PRODUCTS, INTERMEDIATES THEREFORE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE NEW COMPOUNDS AS AN ACTIVE INGREDIENT